Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
GMED Stock Chart & Stats
$62.35
$2.66(3.19%)
At close: 4:00 PM EST
$62.35
$2.66(3.19%)
Day’s Range― - ―
52-Week Range$51.79 - $94.93
Previous CloseN/A
Volume442.39K
Average Volume (3M)1.34M
Market Cap
$8.47B
Enterprise Value$7.95B
Total Cash (Recent Filing)$229.45M
Total Debt (Recent Filing)$121.10M
Price to Earnings (P/E)24.1
Beta0.97
Next Earnings
Nov 06, 2025EPS Estimate
0.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.86
Shares Outstanding112,620,210
10 Day Avg. Volume1,001,523
30 Day Avg. Volume1,342,731
Financial Highlights & Ratios
PEG Ratio-3.60
Price to Book (P/B)2.69
Price to Sales (P/S)4.46
P/FCF Ratio27.70
Enterprise Value/Market Cap0.94
Enterprise Value/Revenue3.03
Enterprise Value/Gross Profit4.82
Enterprise Value/Ebitda12.84
Forecast
1Y Price Target
$81.67Price Target Upside30.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe Nevro acquisition is expected to be accretive to earnings in year 2, supported by ongoing SG&A optimization and expanded commercial leverage through its broader spine infrastructure.
EarningsQ2 EPS was well ahead of consensus as Nevro dilution was less than feared.
Product InnovationRecently, GMED received FDA clearance for Excelsius XR, a head-mounted augmented reality navigation headset.
Bears Say
CEO TransitionThe CEO transition raises questions about the stability and future direction of the company, especially with the competitive nature of the spine industry.
Growth ChallengesThere is a need for a significant step-up in growth in the second half of FY25, prompting concerns about whether the current growth rate sets a new low bar.
Sales ExpectationsExpectations for Enabling Tech are lowered due to GMED's commentary and an expected potentially sticky elongated capital cycle.
Globus Medical News
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $51.79 and its highest was $94.93 in the past 12 months.
What is Globus Medical’s market cap?
Globus Medical’s market cap is $8.47B.
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Nov 06, 2025 which is in 13 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on Aug 07, 2025. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.753 by $0.107.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Undervalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is 0.78.
How many shares outstanding does Globus Medical have?
Globus Medical has 112,620,210 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.86 in its last earnings report, beating expectations of $0.753. Following the earnings report the stock price went up 8.471%.
Which hedge fund is a major shareholder of Globus Medical?
Currently, no hedge funds are holding shares in GMED
Globus Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$81.67 (30.99% Upside)
$81.67 (30.99% Upside)
Blogger Sentiment
Bullish
GMED Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 872.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days >0.1%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.97%
12-Months-Change
Fundamentals
Return on Equity
8.62%
Trailing 12-Months
Asset Growth
-0.65%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical (GMED) is a leading medical device company focused on developing innovative solutions for the treatment of spinal disorders. Founded in 2003 and headquartered in Audubon, Pennsylvania, the company specializes in spinal implant technologies and instruments that improve patient outcomes. GMED's core product offerings include spinal fusion devices, minimally invasive surgical products, and advanced technologies for spinal surgery, addressing the needs of neurosurgeons and orthopedic surgeons worldwide.
GMED Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call depicts a strong quarter for Globus Medical, highlighted by significant revenue growth, a successful integration of Nevro, and continued innovation. Despite some challenges in international markets and lingering supply chain issues, the overall performance and future outlook appear positive.View all GMED earnings summariesGMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
GMED Stock 12 Month Forecast
Average Price Target
$81.67
▲(30.99% Upside)
Technical Analysis
Boston Scientific
―
Koninklijke Philips
―
Smith & Nephew Snats
―
Stryker
―
Zimmer Biomet Holdings
―
Ownership Overview
0.70% Insiders
32.43% Mutual Funds
0.94% Other Institutional Investors
44.71% Public Companies and
Individual Investors